Adamantinoma

Adamantinoma' is a rare type of bone cancer that primarily affects the long bones, especially the tibia (shinbone) and, less frequently, the femur (thighbone). This tumor is characterized by its slow growth and the potential to metastasize, particularly to the lungs and lymph nodes. The etiology of adamantinoma remains largely unknown, and it is often diagnosed through a combination of imaging studies and histopathological examination.

Epidemiology

Adamantinoma is an uncommon neoplasm, accounting for less than 1% of all primary bone tumors. It can occur at any age but is most frequently diagnosed in adults in their second and third decades of life. There is a slight male predominance.

Clinical Presentation

Patients with adamantinoma typically present with a long history of pain and swelling in the affected limb. The tumor's slow-growing nature means that symptoms can be present for several years before diagnosis. Occasionally, a pathological fracture may be the first indication of the disease.

Diagnosis

The diagnosis of adamantinoma involves a combination of clinical evaluation, imaging, and histological analysis.

Imaging

Radiographically, adamantinoma may show a lytic lesion in the diaphysis of long bones with cortical thickening and a multilocular appearance. Magnetic resonance imaging (MRI) and computed tomography (CT) scans provide more detailed visualization of the tumor's extent and its relationship with surrounding structures.

Histopathology

Histologically, adamantinoma is characterized by islands of epithelial cells within a fibrous stroma. It is crucial to differentiate adamantinoma from other bone tumors, such as osteofibrous dysplasia, which it can closely resemble.

Treatment

The mainstay of treatment for adamantinoma is surgical resection with wide margins to minimize the risk of recurrence. In cases where the tumor is located in a limb, limb-sparing surgery is preferred over amputation. The role of chemotherapy and radiation therapy in the treatment of adamantinoma is not well established due to the tumor's rarity.

Prognosis

The prognosis for patients with adamantinoma depends on several factors, including the size and location of the tumor, the presence of metastases at diagnosis, and the completeness of surgical resection. Although adamantinoma is considered a low-grade malignancy, it has a propensity for local recurrence and distant metastasis, which can adversely affect the outcome.

See Also

• Bone tumor
• Osteosarcoma
• Ewing's sarcoma

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian